Digital Pharma Advances Conference
January 28, 2026 - GBGlobal Insight Conferences
callin@gicconferences.com
Phone:02034792299
The 14th Annual Digital Pharma Advances Conference returns to the Grand Connaught Rooms, London, uniting 35+ senior executives from 13 of the world's top 20 pharmaceutical companies — including AstraZeneca, Pfizer, Novartis, Novo Nordisk, GSK, Teva, Bayer, and Roche — to explore practical AI applications, omnichannel marketing strategies, HCP engagement, and patient-centric approaches. Conference Highlights – 28th January High-Impact Digital Strategies Kick off with insights on streamlining digital platforms, balancing online and face-to-face interactions, and leveraging data to measure ROI. Speaker: Sara Tea Di Niro, Teva. AI in Action: Practical, Scalable Solutions Explore responsible AI adoption, governance, and real-world applications that enhance engagement while keeping humans in the loop. Speaker: Margarida Batista, Grünenthal Group. Optimised HCP Engagement Panel Learn how to capture HCP attention with personalised, data-driven content. Speakers include Craig Adkins (Takeda), Kiren Kaur Dulai (Mundipharma), and Jag Singh (CSL Vifor). Data and Omnichannel Insights Deep-dive into using analytics to drive personalised content and optimise every touchpoint across channels. Speakers include Adam Thornton (Bristol Myers Squibb) and Ryan Twiname (LEO Pharma). Patient-Centric Engagement and Compliance Focus on patient needs, transparency, and ethical digital strategies, alongside practical guidance on regulatory compliance. Speakers include Simeón Baker (Genomics England) and Antonios Roussos (Astellas Pharma). Pre-Conference AI Applications Workshop – 27th January New for 2026, the half-day AI workshop offers hands-on, practical insights for pharma marketing teams. Attendees will learn how to: – Enhance HCP engagement through AI – Streamline omnichannel communications – Apply real-world AI use cases while staying compliant Early bird tickets are available until Thursday, with savings of up to £379. Group discounts are also available. Discover the strategies driving pharma innovation in 2026.